CORE 2020
Details
Digital CORE is Abbot’s first live online symposium, including live streamed presentations from the London studio and live-cases from Belfast. In addition, there will be multiple features for you to interact with the faculty and other viewers.
Date
- America/New_York
Adrian Banning
A consultant cadiologist at John Radcliffe Hospital, Oxford University, Oxford, UK. Features in...
Read MoreA consultant cadiologist at John Radcliffe Hospital, Oxford University, Oxford, UK. Features in 13 videos on Wondr Medical. Adrian Banning generally speaks on Bifurcation, Left Main Stem (LMS), Intravascular Ultrasound (IVUS), Coronary Optical Coherence Tomography (OCT), and Multi Vessel Disease.
Show LessAndrew Glass
Andrew Glass is a regional director at Abbott Vascular, London, UK.
Read MoreAndrew Glass is a regional director at Abbott Vascular, London, UK.
Show LessColm Hanratty
A consultant cardiologist at Mater Private Hospital, Dublin, Ireland. Features in 20 videos on...
Read MoreA consultant cardiologist at Mater Private Hospital, Dublin, Ireland. Features in 20 videos on Wondr Medical. Colm Hanratty generally speaks on Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Chronic Total Occlusion (CTO), Calcium Scoring, and Stable Coronary Artery Disease (CAD).
Show LessDivaka Perera
Divaka Perera graduated in medicine from Cambridge University and completed his early clinical...
Read MoreDivaka Perera graduated in medicine from Cambridge University and completed his early clinical training at Addenbrooke’s, Papworth and West Suffolk hospitals. He undertook specialist training in cardiology in south London and sub-speciality training in interventional cardiology at Guy’s and St Thomas’ NHS Foundation Trust and Brighton and Sussex University Hospitals. In 2008, he received a senior lectureship award from the Department of Health, Higher Education Funding Council for England (HEFCE) and the UK Clinical Research Collaboration (UKCRC). He was also appointed to the post of consultant cardiologist at Guy’s and St Thomas’ Hospital. He was promoted to reader in interventional cardiology in 2013 and to professor of cardiology in 2017. In addition to his clinical and research roles, he teaches undergraduate medical students and supervises postgraduate researchers towards MSc, MD and PhD degrees at King’s College London.
Show LessJames Spratt
James Spratt Professor of Interventional cardiology with a sub-speciality interest in complex...
Read MoreJames Spratt Professor of Interventional cardiology with a sub-speciality interest in complex PCI, intravascular imaging and CTO. He is widely published within this area and has performed live case demonstrations globally. He has an interest in medical education and is the Founder of Optima Education.
Show LessJonathan Hill
Consultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton...
Read MoreConsultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton Hospital, London. His clinical focus is on use of intravascular imaging in complex PCI , CTO and cardiogenic shock. His clinical research interests focus on optical coherence tomography, calcific coronary disease and percutaneous ventricular support. Dr Hill was global co-chief investigator for the DISRUPT CAD III study and has served as UK principal investigator for multiple interventional trials. He has served as a CTO and complex PCI proctor on a global basis and works closely with OPTIMA to focus on the development of OPTIMAL PCI. He is the founding co-director of the Complete Revascularisation (CoRe) meetings held every year in London.
Show Lessnick curzen
A consultant cardiologist at Wessex Cardiothoracic Unit, Southampton University Hospital,...
Read MoreA consultant cardiologist at Wessex Cardiothoracic Unit, Southampton University Hospital, Southampton, UK. Features in 14 videos on Wondr Medical. Nick Curzen generally speaks on Covid19 Managing Covid, Coronary Interventions, Left Main Stem (LMS), Anti-Platelet Drugs , and Drug Eluting Stents (DES).
Show LessPeter O'Kane
Dr Peter O’Kane graduated from Charing Cross & Westminster Medical School in 1995 with First...
Read MoreDr Peter O’Kane graduated from Charing Cross & Westminster Medical School in 1995 with First Class Honours Bachelor of Science BSc degree in Physiology, Medical Degree and numerous prizes including the Llewelyn Prize for the second-best distinction in medical finals. After attaining membership of the Royal College of Physicians he was subsequently awarded a Doctorate of Medicine by the University of London for a thesis on the role of nitric oxide in coronary heart disease. Dr O’Kane was appointed as Consultant Interventional Cardiologist at the Royal Bournemouth Hospital in July 2007. He has performed over 7000 PCI procedures as a Consultant. He routinely treats extensively calcified lesions, bifurcations including left main stem disease & chronic total occlusions. He is committed to teaching & education with local fellowship training program through to national & international proctorship of techniques & multiple adjunctive devices. He has trained Consultant colleagues from the UK, Europe, Asia & USA through local workshops and courses. He is regularly invited as faculty to National & International meetings as a presenter & live case operator. He has published over 70 manuscripts and authored 10 book chapters. He is a local principal Investigator for over 30 National & International multi-centre clinical trials & is dedicated to patient recruitment with over 900 patients recruited to trials he has managed. He has led numerous quality improvement programs, is PCI Lead, Cardiology Governance and Mortality Lead & has achieved National Bronze Clinical Excellence Award level 9. He was a nationally elected member to British Cardiovascular Intervention Society (BCIS) Council (2020-2023) and from March 2023 is a member of BCIS Research Working Group.
Show LessRasha Al-Lamee
Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS...
Read MoreDr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al- Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.
Show LessSimon Walsh
Dr Simon Walsh has been working as a Consultant Cardiologist at the Belfast Trust for over 10...
Read MoreDr Simon Walsh has been working as a Consultant Cardiologist at the Belfast Trust for over 10 years. It is one of the largest NHS trusts in the UK. The centre performs ~2750 PCI per year, with 650-700 STEMI and calcium modification in ~10% of our PCI cases. Dr Walsh also works internationally as an educator, teaching advanced techniques for complex PCI and CTO PCI. This involves training visiting Cardiologists in Belfast retrograde CTO techniques, antegrade dissection and re-entry CTO techniques and other advanced PCI procedures. He has visited multiple centres in the UK, Ireland, Europe, Australia, Asia and North America to act as a visiting proctor for complex PCI and CTO PCI cases. Dr Walsh’s research interests include PCI, coronary artery disease, defibrillation, acute coronary syndromes and chronic total occlusions. Research responsibilities have included acting as a recruiting investigator for the >25 multicentre studies over the last 17 years. He acted as a primary investigator for numerous international trials including the Evolve, Noble, Leaders Free and Ischemia multicentre studies. He has been the lead UK investigator for the October trial, Syntax 2, Recharge and Ischaemia-CTO. He is also the Chief Investigator for the Consistent CTO, Celtic Bifurcation and Discrete CTO trials.
Show LessYundai Chen
An interventional cardiologist at Chinese PLA General Hospital, Beijing, China. Features in 1...
Read MoreAn interventional cardiologist at Chinese PLA General Hospital, Beijing, China. Features in 1 video on Wondr Medical. Yundai Chen generally speaks on Covid19 Webinars and Discussions and Coronary Interventions.
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show Less